Key statistics
As of last trade, Telesis Bio Inc (TBIO:PKC) traded at 2.25, 76.77% above the 52 week low of 1.27 set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.00 |
---|---|
High | 2.25 |
Low | 2.00 |
Bid | -- |
Offer | -- |
Previous close | 2.05 |
Average volume | 3.21m |
---|---|
Shares outstanding | 1.77m |
Free float | 1.10m |
P/E (TTM) | -- |
Market cap | 3.98m USD |
EPS (TTM) | -29.66 USD |
Data delayed at least 15 minutes, as of Oct 08 2024.
More ▼
Announcements
- Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
- Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
- Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
- Telesis Bio Reports First Quarter 2024 Financial Results
- Telesis Bio Announces Reverse Stock Split
- Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
- Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
- Telesis Bio Reports Third Quarter 2023 Financial Results
- Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
More ▼